SCHEMBL6174877

SCHEMBL6174877

CN(C)c1cccc2c(CC3(C)NC(=O)N(c4ccc(SC(F)(F)F)cc4)C3=O)ccnc12

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 19/20 0.43
NTRK1 P04629 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174978 0.88 IGF1R (0.43) IGF1RNTRK1
SCHEMBL6171778 0.87 IGF1R (0.40) IGF1RNTRK1
SCHEMBL6172537 0.86 IGF1R (0.43) IGF1R
SCHEMBL6175888 0.86 GRM5 (0.35) IGF1RNTRK1
SCHEMBL6175028 0.85 IGF1R (0.45) IGF1RNTRK1
SCHEMBL6173427 0.85 IGF1R (0.45) IGF1RNTRK1
SCHEMBL6175587 0.82 IGF1R (0.45) IGF1R
SCHEMBL2940465 0.81 IGF1R (0.62) IGF1R
Trifluoroacetic Acid SCHEMBL17558379 0.81 IGF1R (0.42) IGF1RNTRK1
SCHEMBL6174389 0.80 IGF1R (0.42) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed